Armata Pharmaceuticals (ARMP) Net Cash Flow: 2013-2018
Historic Net Cash Flow for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to $2.4 million.
- Armata Pharmaceuticals' Net Cash Flow rose 190.98% to $2.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.3 million, marking a year-over-year increase of 320.73%. This contributed to the annual value of -$4.5 million for FY2024, which is 185.02% down from last year.
- According to the latest figures from Q4 2018, Armata Pharmaceuticals' Net Cash Flow is $2.4 million, which was up 213.69% from -$2.1 million recorded in Q3 2018.
- Armata Pharmaceuticals' Net Cash Flow's 5-year high stood at $10.0 million during Q1 2015, with a 5-year trough of -$3.9 million in Q1 2014.
- Its 3-year average for Net Cash Flow is -$579,000, with a median of -$2.1 million in 2018.
- Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 2,641.26% in 2014, then surged by 356.22% in 2015.
- Over the past 5 years, Armata Pharmaceuticals' Net Cash Flow (Quarterly) stood at -$3.2 million in 2014, then climbed by 26.15% to -$2.4 million in 2015, then surged by 173.68% to $1.7 million in 2016, then slumped by 248.68% to -$2.6 million in 2017, then skyrocketed by 190.98% to $2.4 million in 2018.
- Its Net Cash Flow stands at $2.4 million for Q4 2018, versus -$2.1 million for Q3 2018 and -$2.1 million for Q2 2018.